ArticleScientific reports2026
Benchmarking MedViT and hybrid CNN-ViT architectures for multi-label thoracic disease classification.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Computer-aided diagnosis relies heavily on the automatic classification of thoracic diseases from chest X-ray (CXR) images, yet this task remains challenging due to class imbalance, overlapping radiological features, and high inter-class similarity. In this study, two architectures MedViT and Hybrid CNN–ViT are adapted and evaluated, which are a scalable Vision Transformer (ViT)-based architecture designed for multi-label thoracic disease classification. MedViT is enhanced with transfer learning, domain-specific augmentations, and self-attention mechanisms to capture subtle pathological patterns across diverse conditions. The Hybrid CNN–ViT is the combination of strength of CNN and ViT which is admirable in capturing local patterns. Both models are trained and validated on two benchmark datasets, NIH ChestX-ray14 and CheXpert, and compared against state-of-the-art baselines. On the NIH ChestX-ray14 dataset, MedViT showed strong performance with 93.34% accuracy and a macro AUROC of 94.17%, while the Hybrid CNN–ViT model reached 85.81% accuracy and 72.28% macro AUROC. On the CheXpert dataset, MedViT achieved 79.22% accuracy and a macro AUROC of 75.11%, whereas Hybrid CNN–ViT achieved 76.15% accuracy and 71.68% macro AUROC. These results show that MedViT performs well and generalizes effectively across different datasets. Per-label analysis demonstrated robust precision and recall even for under-represented conditions such as fibrosis and hernia, where existing models typically show significant performance drops. Unlike earlier methods that often struggle with generalization, MedViT maintains a balanced trade-off between sensitivity and specificity across all categories. These findings highlight the effectiveness of Transformer-based feature encoding in capturing subtle spatial correlations in medical imaging, while also setting new benchmarks for automated thoracic disease classification. The MedViT model outperformed the state-of-the-art methods and shows strong potential to support radiologists in decision-making and improve diagnostic workflows in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.